Benzinga
2022.06.22 13:47

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates TPTX, DRE, ELSE, PLD

NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Turning Point Therapeutics, Inc. (NASDAQ:TPTX)'s sale to Bristol Myers Squibb for $76.00 per share. If you are a Turning Point shareholder, click here to learn more about your rights and options.

The copyright of this article belongs to the original author/organization.
The current content only represents the author’s point of view, and has nothing to do with the position of Longbridge. The content is for investment reference only and does not constitute any investment advice. If you have any questions or suggestions about the content services provided by Longbridge, please contact: editorial@longbridge.global

Like